Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
This week the U.S. Food and Drug Administration expanded the use of the drug ibrutinib to treat patients who have chronic lymphocytic leukemia (CLL) – with UR Medicine’s James P. Wilmot Cancer Center participating in research that supported accelerated approval of the drug.
2/13/2014 | 0 comments
Obese women expecting twins may be able to gain less weight than recommended without harming their babies, according to a new study presented at The Pregnancy Meeting of the Society for Maternal-Fetal Medicine.
2/12/2014 | 2 comments
Current efforts to grade the quality of care hospitals provide stroke patients have a big flaw according to a new study in the journal Stroke. Measures of mortality – whether or not a stroke patient dies shortly after being admitted to a hospital – do not take into account whether these deaths occurred because of poor care or because physicians were carrying out the wishes of the patient and their family to withhold care.
2/12/2014 | 0 comments
The drug tamoxifen appears to kill a fungus associated with a deadly brain infection that afflicts HIV/AIDS patients, according to a new University of Rochester study in mBio, the journal of the American Society for Microbiology.
2/11/2014 | 0 comments
A new UR contest is encouraging students and trainees, as well as the whole research community, to think about how to turn advances in basic and applied sciences more quickly – and safely – into new ways to improve health.
2/7/2014 | 3 comments